Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasisStereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis

TY - JOUR

T1 - Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasisStereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis

AU - Samuel T Chao, Joseph M Kim, Jacob A Miller, Rupesh Kotecha,

AU - Ahluwalia, Manmeet

AU - John H Suh, David M Peereboom, Alireza M Mohammadi, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum, Lilyana Angelov, Jame Abraham, Halle Moore, G Thomas Budd,

N1 - 1 School of Medicine, Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio. 2 Department of Radiation Oncology, Stanford Cancer Institute, Stanford University Medical Center, Palo Alto, California. 3 Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida. 4 Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

PY - 2019/5/6

Y1 - 2019/5/6

UR - https://pubmed.ncbi.nlm.nih.gov/30726965/

M3 - Article

VL - 21

JO - Neuro-oncology

JF - Neuro-oncology

ER -